4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-23-000242
Director sold 3,000 shares at $120.00 ($360,004)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ALTMAN STEVEN R Director | 2023-12-12 | Sale 10b5-1 | −3,000 | $120.00 | $360,004 | 56,700 | I: show line 1 in the form |
| Open-market sales · 3,000 sh · avg $120.00 · $360,004 | |||||||
Loading xslF345X05/edgardoc.xml…